Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FJT41
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,348
Award facts
- Contract value 100% obligated
- $33,347.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $33,347.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose, 2 pens per milliliter, with an ultimate completion date of September 4, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. The place of performance is located at the vendor's corporate office in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. Cosentyx is a biologic medication used in the treatment of autoimmune conditions, and this delivery order fulfills immediate medical supply needs within the broader global pharmaceutical support vehicle managed by DLA. The company's extensive portfolio of federal contract awards demonstrates its role as a primary supplier across multiple therapeutic domains for the Defense Health Agency and related government healthcare systems, with contract values ranging from routine supply orders to substantial pharmaceutical shipments.
Quick answers
Who was awarded contract SPE2DB25FJT41?
SPE2DB25FJT41 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FJT41 worth?
The government has obligated $33,348 on SPE2DB25FJT41.
Is contract SPE2DB25FJT41 an order under another contract?
Yes. SPE2DB25FJT41 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJT41 competed?
The extent of competition for SPE2DB25FJT41 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award